Author

Сафарова Альфия Риядовна

Observed names: A. R. Safarova, A. Safarova, Alfiya R. Safarova

Institution: Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigal

Observed institutions: Republican Oncological Clinical Dispensary, Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigal

ORCID: 0000-0002-2988-3746

Observed ORCID: 0000-0002-2988-3746

OpenAlex ID: A5074223749

Efficacy and tolerability of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer: results of a multicenter observational study in the Russian Federation

2020 · E. V. Borodavina, P. A. Isaev, et al. · Head and neck tumors (HNT) · 6

Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study

2024 · Maria I. Volkova, Alexey S. Kalpinskiy, et al. · Journal of Modern Oncology · 2

Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice

2022 · V. V. Petkau, A. V. Sultanbaev, et al. · Russian Journal of Gastroenterology Hepatology Coloproctology · 2

Efficacy of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell carcinoma

2024 · M. I. Volkova, A. S. Kalpinskiy, et al. · Cancer Urology · 1

Real-world efficacy and safety of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: Updated data from a Russian observational study

2025 · Maria I. Volkova, Alexey S. Kalpinskiy, et al. · Journal of Modern Oncology

Final data on the eﬃcacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world eﬃcacy of prolgolimab in patients with metastatic melanoma in Russia

2024 · Kristina V. Orlova, Mikhail Fedyanin, et al. · Journal of Modern Oncology

Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study

2021 · E. I. Kovalenko, E. V. Artamonova, et al. · Meditsinskiy sovet = Medical Council

Efficacy and safety of eribulin in combination with trastuzumab in HER2-positive metastatic breast cancer patients: Real life experience

2020 · E. Kovalenko, L. Manzyuk, et al. · European Journal of Cancer

Эффективность и безопасность ленватиниба с пембролизумабом при распространенном почечноклеточном раке в реальной практике: обновленные данные российского наблюдательного исследования

· Волкова Мария Игоревна, Калпинский Алексей Сергеевич, et al. · CyberLeninK (CyberLeninka)

Works count: 12

Citation count: 11

H-index: 2

I10-index: